PLIANT THERAPEUTICS, INC. Unrealized Gain (Loss) on Investments
PLIANT THERAPEUTICS, INC. (PLRX) reported Unrealized Gain (Loss) on Investments of -$287.00 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2025-11-06
- PLIANT THERAPEUTICS, INC. unrealized gain (loss) on investments for the quarter ending 2025-09-30 was $35.00K, a 97.61% decline year-over-year.
- PLIANT THERAPEUTICS, INC. unrealized gain (loss) on investments for the quarter ending 2025-06-30 was -$160.00K.
- PLIANT THERAPEUTICS, INC. unrealized gain (loss) on investments for the quarter ending 2025-03-31 was -$162.00K.
- PLIANT THERAPEUTICS, INC. unrealized gain (loss) on investments for the quarter ending 2024-12-31 was -$527.00K, a 123.40% decline year-over-year.
- PLIANT THERAPEUTICS, INC. unrealized gain (loss) on investments for fiscal 2024 was -$24.00K, a 101.04% decline from fiscal 2023.
- PLIANT THERAPEUTICS, INC. unrealized gain (loss) on investments for fiscal 2023 was $2.30M.
- PLIANT THERAPEUTICS, INC. unrealized gain (loss) on investments for fiscal 2022 was -$1.76M.
- PLIANT THERAPEUTICS, INC. unrealized gain (loss) on investments for fiscal 2021 was -$169.00K.
| Period end | Unrealized Gain (Loss) on Investments 3 month | Unrealized Gain (Loss) on Investments 6 month | Unrealized Gain (Loss) on Investments 9 month | Unrealized Gain (Loss) on Investments 12 month |
|---|---|---|---|---|
| 2025-09-30 | $35.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$125.00K derived: sum of 2 quarters · filed 2025-11-06 | -$287.00K 10-Q · filed 2025-11-06 | -$814.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-06-30 | -$160.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$322.00K 10-Q · filed 2025-08-07 | -$849.00K derived: sum of 3 quarters · filed 2025-08-07 | $616.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-03-31 | -$162.00K 10-Q · filed 2025-05-08 | -$689.00K derived: sum of 2 quarters · filed 2025-05-08 | $776.00K derived: sum of 3 quarters · filed 2025-11-06 | $648.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-12-31 | -$527.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $938.00K derived: sum of 2 quarters · filed 2025-11-06 | $810.00K derived: sum of 3 quarters · filed 2025-11-06 | -$24.00K 10-K · filed 2025-03-03 |
| 2024-09-30 | $1.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.34M derived: sum of 2 quarters · filed 2025-11-06 | $503.00K 10-Q · filed 2025-11-06 | $2.75M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$128.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$962.00K 10-Q · filed 2025-08-07 | $1.29M derived: sum of 3 quarters · filed 2025-08-07 | $1.62M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$834.00K 10-Q · filed 2025-05-08 | $1.42M derived: sum of 2 quarters · filed 2025-05-08 | $1.75M derived: sum of 3 quarters · filed 2025-05-08 | $833.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $2.59M derived: sum of 2 quarters · filed 2025-03-03 | $1.67M derived: sum of 3 quarters · filed 2025-03-03 | $2.30M 10-K · filed 2025-03-03 |
| 2023-09-30 | $334.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$585.00K derived: sum of 2 quarters · filed 2024-11-07 | $51.00K 10-Q · filed 2024-11-07 | -$3.96M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | -$919.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$283.00K 10-Q · filed 2024-08-07 | -$4.29M derived: sum of 3 quarters · filed 2025-03-03 | -$982.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $636.00K 10-Q · filed 2024-05-06 | -$3.37M derived: sum of 2 quarters · filed 2025-03-03 | -$63.00K derived: sum of 3 quarters · filed 2025-03-03 | -$372.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | -$4.01M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$699.00K derived: sum of 2 quarters · filed 2025-03-03 | -$1.01M derived: sum of 3 quarters · filed 2025-03-03 | -$1.76M 10-K · filed 2025-03-03 |
| 2022-09-30 | $3.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $3.00M derived: sum of 2 quarters · filed 2023-11-09 | $2.25M 10-Q · filed 2023-11-09 | $2.09M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | -$309.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$1.06M 10-Q · filed 2023-08-09 | -$1.22M derived: sum of 3 quarters · filed 2024-02-27 | -$1.23M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | -$749.00K 10-Q · filed 2023-05-09 | -$910.00K derived: sum of 2 quarters · filed 2024-02-27 | -$920.00K derived: sum of 3 quarters · filed 2024-02-27 | -$932.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | -$161.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$171.00K derived: sum of 2 quarters · filed 2024-02-27 | -$183.00K derived: sum of 3 quarters · filed 2024-02-27 | -$169.00K 10-K · filed 2024-02-27 |
| 2021-09-30 | -$10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$22.00K derived: sum of 2 quarters · filed 2022-11-08 | -$8.00K 10-Q · filed 2022-11-08 | -$22.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | -$12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $2.00K 10-Q · filed 2022-08-08 | -$12.00K derived: sum of 3 quarters · filed 2022-08-08 | $0.00 derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $14.00K 10-Q · filed 2022-05-09 | $0.00 derived: sum of 2 quarters · filed 2022-05-09 | $12.00K derived: sum of 3 quarters · filed 2022-05-09 | -$77.00K derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | -$14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$2.00K derived: sum of 2 quarters · filed 2022-03-01 | -$91.00K derived: sum of 3 quarters · filed 2022-03-01 | -$31.00K 10-K · filed 2022-03-01 |
| 2020-09-30 | $12.00K 10-Q · filed 2020-11-10 | -$77.00K derived: sum of 2 quarters · filed 2020-11-10 | -$17.00K 10-Q · filed 2021-11-09 | -$19.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | -$89.00K 10-Q · filed 2020-08-11 | -$29.00K 10-Q · filed 2021-08-09 | -$31.00K derived: sum of 3 quarters · filed 2022-03-01 | -$41.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $60.00K 10-Q · filed 2021-05-10 | $58.00K derived: sum of 2 quarters · filed 2022-03-01 | $48.00K derived: sum of 3 quarters · filed 2022-03-01 | $56.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$12.00K derived: sum of 2 quarters · filed 2022-03-01 | -$4.00K derived: sum of 3 quarters · filed 2022-03-01 | -$1.00K 10-K · filed 2022-03-01 |
| 2019-09-30 | -$10.00K 10-Q · filed 2020-11-10 | -$2.00K derived: sum of 2 quarters · filed 2020-11-10 | $1.00K 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $8.00K 10-Q · filed 2020-08-11 | $11.00K 10-Q · filed 2020-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |